Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glictif-M Tablet

Prescription Icon
Prescription Required

Marketer

Positif Life sciences

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glictif-M Tablet

Diabex Duo tablets are a dual-action antidiabetic medication prescribed for adult patients with type 2 diabetes. This combined formulation helps regulate blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar readings. Continued use is vital, even with well-controlled blood sugar; abrupt cessation, without medical consultation, risks elevated glucose levels and potential complications including nephropathy, retinopathy, neuropathy, and peripheral vascular disease. Diabex Duo is a component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are crucial for effective diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation, and nausea. Knowing how to treat hypoglycemia—carrying a fast-acting glucose source, such as sugary snacks or juice—is essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, diarrhea, abdominal discomfort, and upper respiratory infections. Weight gain may occur. Diabex Duo is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before initiating treatment. Consult your physician before using this medication if pregnant or breastfeeding. Regular blood glucose monitoring is necessary, along with periodic blood tests to assess blood cell counts and liver function.

Uses of Glictif-M Tablet

Adult-onset diabetes

Major Benefits of Glictif-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glictif-M Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

Common Side effects of Glictif-M Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glictif-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glictif-M Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.

How Glictif-M Tablet works:

Glictif-M tablets contain gliclazide and metformin, two medications used to manage blood sugar levels in patients with diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Glictif-M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glictif-M Tablets is contraindicated in pregnancy due to established risks to fetal development. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Glictif-M Tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when administering Glictif-M Tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Glictif-M Tablets are contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Glictif-M tablets. Dosage modification may be necessary, and medical advice is recommended. A reduced initial dose is typically advised for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glictif-M Tablet :

Should you forget a Glictif-M Tablet dose, take it promptly. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Glictif-M Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Medication

FAQs on Glictif-M Tablet

Glictif-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glictif-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glictif-M Tablets can cause low blood sugar (hypoglycemia), leading to symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other diabetes medication is taken concurrently. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glictif-M Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and/or bradycardia. If these occur, discontinue Glictif-M and seek immediate medical attention.
Prolonged Glictif-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait problems), urinary issues, cognitive changes, and balance difficulties. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Glictif-M Tablets are contraindicated in patients with hypersensitivity to any ingredient or excipient. They should also not be used in patients with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glictif-M Tablet and alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Glictif-M tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glictif-M is not suitable for type 1 diabetes.
Glictif-M Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glictif-M Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glictif-M Tablet use can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). While rare, this side effect is more likely in patients with kidney disease, older individuals, or those consuming excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glictif-M and seek immediate medical attention.
Prolonged Glictif-M Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (including tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glictif-M Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glictif-M tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glictif-M Tablet
57
MRP 69
17% off